82 related articles for article (PubMed ID: 20643295)
1. Metal cation-fluoroquinolone complexes do not permeate through the intestinal absorption barrier.
Simon Z; Katja B; Darko U; Marjan V; Albin K
J Pharm Biomed Anal; 2010 Nov; 53(3):655-9. PubMed ID: 20643295
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin permeability and its active secretion through rat small intestine in vitro.
Zakelj S; Sturm K; Kristl A
Int J Pharm; 2006 Apr; 313(1-2):175-80. PubMed ID: 16529884
[TBL] [Abstract][Full Text] [Related]
3. Effect of metal ions on some pharmacologically relevant interactions involving fluoroquinolone antibiotics.
Seedher N; Agarwal P
Drug Metabol Drug Interact; 2010; 25(1-4):17-24. PubMed ID: 21417790
[TBL] [Abstract][Full Text] [Related]
4. [In vivo effect of food on absorption of fluoroquinolones].
Füredi P; Pápai K; Budai M; Ludányi K; Antal I; Klebovich I
Acta Pharm Hung; 2009; 79(2):81-7. PubMed ID: 19634639
[TBL] [Abstract][Full Text] [Related]
5. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin.
Rodríguez-Ibáñez M; Sánchez-Castaño G; Montalar-Montero M; Garrigues TM; Bermejo M; Merino V
Int J Pharm; 2006 Jan; 307(1):33-41. PubMed ID: 16257153
[TBL] [Abstract][Full Text] [Related]
7. Influence of metal cations on the solubility of fluoroquinolones.
Zakelj S; Berginc K; Ursic D; Kristl A
Pharmazie; 2007 Apr; 62(4):318-20. PubMed ID: 17484293
[TBL] [Abstract][Full Text] [Related]
8. Membrane permeability in the gastrointestinal tract: the interplay between microclimate pH and transporters.
Kristl A
Chem Biodivers; 2009 Nov; 6(11):1923-32. PubMed ID: 19937830
[TBL] [Abstract][Full Text] [Related]
9. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
[TBL] [Abstract][Full Text] [Related]
10. Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells.
Fernandez-Teruel C; Gonzalez-Alvarez I; Casabó VG; Ruiz-Garcia A; Bermejo M
J Drug Target; 2005 Apr; 13(3):199-212. PubMed ID: 16036308
[TBL] [Abstract][Full Text] [Related]
11. Drug-drug interactions with fluoroquinolones.
Marchbanks CR
Pharmacotherapy; 1993; 13(2 Pt 2):23S-28S. PubMed ID: 8474934
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modeling of oral absorption and bioavailability of a fluoroquinolone after its precipitation in the gastrointestinal tract.
Fernandez-Teruel C; Mangas-Sanjuan V; Gonzalez-Alvarez I; Ruiz-Garcia A; Casabó VG; Bermejo M
Xenobiotica; 2013 Sep; 43(9):745-54. PubMed ID: 23294363
[TBL] [Abstract][Full Text] [Related]
13. Comparative in situ study of the intestinal absorption of aluminum, manganese, nickel, and lead in rats.
Arnich N; Cunat L; Lanhers MC; Burnel D
Biol Trace Elem Res; 2004; 99(1-3):157-71. PubMed ID: 15235150
[TBL] [Abstract][Full Text] [Related]
14. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the factors that significantly influence the stability of fluoroquinolone-metal complexes.
Urbaniak B; Kokot ZJ
Anal Chim Acta; 2009 Aug; 647(1):54-9. PubMed ID: 19576385
[TBL] [Abstract][Full Text] [Related]
16. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
17. In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration.
Brillault J; Tewes F; Couet W; Olivier JC
Eur J Pharm Sci; 2017 Jan; 97():92-98. PubMed ID: 27863308
[TBL] [Abstract][Full Text] [Related]
18. Predicting the human jejunal permeability and fraction absorbed of fluoroquinolones based on a biophysical model.
Wang C; Avdeef A; Zhang W; Tam KY
Biomed Mater Eng; 2014; 24(6):3849-54. PubMed ID: 25227102
[TBL] [Abstract][Full Text] [Related]
19. Study on the interaction between fluoroquinolones and erythrosine by absorption, fluorescence and resonance Rayleigh scattering spectra and their application.
Wang J; Liu Z; Liu J; Liu S; Shen W
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Mar; 69(3):956-63. PubMed ID: 17618827
[TBL] [Abstract][Full Text] [Related]
20. Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction.
Spivey JM; Cummings DM; Pierson NR
Pharmacotherapy; 1996; 16(2):314-6. PubMed ID: 8820479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
